Omgo E Nieweg

5PUBLICATIONS
53CO-AUTHORS
Predictive and prognostic markersPlant biology not elsewhere classifiedCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 05, 2024
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator.

Alexander H R Varey, Isabel Li, Mary-Ann El Sharouni

|Dec 14, 2023
Composite haemangioendothelioma with neuroendocrine marker differentiation presenting as a pink-brown nodule.

Chelsea Morgan Ellen Jones, Omgo E Nieweg, Frank Isaacs

|Sep 13, 2022
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes.

Felicity Newell, Peter A Johansson, James S Wilmott

|Feb 09, 2021
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma.

E A Rozeman, E P Hoefsmit, I L M Reijers

|Jul 15, 2017
Role of sentinel lymph node biopsy as a staging procedure in patients with melanoma: A critical appraisal.

Omgo E Nieweg, Alan Cooper, John F Thompson

Pageof 1

Frequent Collaborators

3 joint publications

Robyn P M Saw

3 joint publications

Richard A Scolyer

2 joint publications

Jonathan R Stretch

2 joint publications

Kerwin F Shannon